Hamilton Wealth’s AstraZeneca AZN Stock Holding History

Hamilton Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$442K	Sell	2,329 -880	-27%	-$166K	0.08%	74
2026 Q1	$633K	Sell	3,209 -30	-0.9%	-$5.79K	0.12%	62
2025 Q4	$596K	Buy	3,239 +459	+17%	+$80.5K	0.11%	68
2025 Q3	$427K	Buy	2,780 +1,182	+74%	+$179K	0.09%	72
2025 Q2	$223K	Hold	1,598	–	–	0.05%	93
2025 Q1	$235K	Buy	+1,598	New	+$231K	0.06%	92
2023 Q3	–	Sell	-2,612	Closed	-$374K	–	90
2023 Q2	$374K	Buy	2,612 +44	+2%	+$6.47K	0.13%	60
2023 Q1	$356K	Buy	+2,568	New	+$346K	0.13%	61
2020 Q4	–	Sell	-16,919	Closed	-$1.85M	–	53
2020 Q3	$1.85M	Buy	+16,919	New	+$1.88M	1.04%	36

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hamilton Wealth's AZN Position: Q2 2026 in Review

Hamilton Wealth reduced its AstraZeneca (AZN) stake by 27% in Q2 2026, selling an estimated $166K and leaving 2,329 shares worth $442K. The position accounts for 0.08% of the portfolio, ranked #74.

Hamilton Wealth first reported a position in AZN in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.85M in Q3 2020. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Hamilton Wealth held 2,329 shares of AstraZeneca worth $442K as of Q2 2026.
Hamilton Wealth sold 880 AstraZeneca shares in Q2 2026, an estimated $166K.
AstraZeneca made up 0.08% of Hamilton Wealth's portfolio in Q2 2026, its #74 holding.
Hamilton Wealth first reported a position in AstraZeneca in Q3 2020 and has held it in 9 quarters since.
Hamilton Wealth's AstraZeneca position peaked at $1.85M in Q3 2020.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hamilton Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.